TLR4 and COVID-19: In addition, a possible secondary bacterial infection during the later phase of COVID-19 may result in the stabilization of HIF-1α in macrophages via the activation of toll-like receptor 4 (TLR4) and decrease in prolyl hydroxylase mRNA in severe inflammatory vascular disease (Peyssonnaux et al., 2007).